Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Enhancing Pharmacovigilance Capabilities in the EU Regulatory Network: The SCOPE Joint Action
Anna Radecka, Louise Loughlin, Mick Foy, et al.
Drug Safety (2018) Vol. 41, Iss. 12, pp. 1285-1302
Open Access | Times Cited: 25

Showing 25 citing articles:

A Systematic Review of Pharmacovigilance Systems in Developing Countries Using the WHO Pharmacovigilance Indicators
Hamza Y. Garashi, Douglas Steinke, Ellen Schafheutle
Therapeutic Innovation & Regulatory Science (2022) Vol. 56, Iss. 5, pp. 717-743
Open Access | Times Cited: 28
A new paradigm in adverse drug reaction reporting: consolidating the evidence for an intervention to improve reporting
Raymond Li, Kate Curtis, Syed Tabish R. Zaidi, et al.
Expert Opinion on Drug Safety (2022) Vol. 21, Iss. 9, pp. 1193-1204
Closed Access | Times Cited: 17
Data-Driven Identification of Factors That Influence the Quality of Malaysian Adverse Event Reports: 15-Year Interpretable Machine Learning and Time Series Analyses of QUEST and VigiBase Using vigiGrade (Preprint)
Sim Mei Choo, Daniele Sartori, Sing Chet Lee, et al.
JMIR Medical Informatics (2024) Vol. 12, pp. e49643-e49643
Open Access | Times Cited: 2
Global trends in pharmacovigilance-related events: a 30-year analysis from the 2019 global burden of disease study
Shuzhi Lin, Shuang Lei, Wei Liu, et al.
International Journal of Clinical Pharmacy (2024) Vol. 46, Iss. 5, pp. 1076-1090
Closed Access | Times Cited: 2
The STAR Compass to Guide Future Pharmacovigilance Based on a 10-Year Review of the Strengthened EU System
Priya Bahri, Georgy Genov, Peter Arlett, et al.
Drug Safety (2024) Vol. 47, Iss. 10, pp. 941-956
Open Access | Times Cited: 2
Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance
Priya Bahri, Geoffrey Bowring, Brian Edwards, et al.
Drug Safety (2023) Vol. 46, Iss. 6, pp. 517-532
Open Access | Times Cited: 5
All-round approaches to increase adverse drug reaction reports: a scoping review
João Joaquim, Cristiano Matos, Diana Guerra, et al.
Drugs & Therapy Perspectives (2023) Vol. 39, Iss. 7, pp. 249-261
Closed Access | Times Cited: 4
An exploratory study of knowledge, attitudes, practice and barriers towards adverse drug reaction reporting among healthcare professionals in Malta
Elisa Curtolo, Benjamin Micallef, Janis Vella Szijj, et al.
International Journal of Risk & Safety in Medicine (2024) Vol. 35, Iss. 3, pp. 271-286
Closed Access | Times Cited: 1
Patient and Public Involvement in Pharmacovigilance
Florence van Hunsel, Manal M. Younus, Anthony R. Cox
Springer eBooks (2024), pp. 273-293
Closed Access | Times Cited: 1
Knowledge, attitude, practice and barriers towards pharmacovigilance and adverse drug reactions reporting among healthcare professionals in Turkey: a systematic review
Zakir Khan, Yusuf Karataş, Maria Auxiliadora Parreiras Martins, et al.
Current Medical Research and Opinion (2021) Vol. 38, Iss. 1, pp. 145-154
Closed Access | Times Cited: 11
Making medicines safer: analysis of patient reports to the UK’s Yellow Card Scheme
Bernadine O’Donovan, Ruth Rodgers, Anthony R. Cox, et al.
Expert Opinion on Drug Safety (2019) Vol. 18, Iss. 12, pp. 1237-1243
Open Access | Times Cited: 9
Regulatory experience of handling Risk Management Plans (RMPs) for medicinal products in the EU
Dianne Butler, Katarina Vučić, Sabine M. J. M. Straus, et al.
Expert Opinion on Drug Safety (2021) Vol. 20, Iss. 7, pp. 815-826
Closed Access | Times Cited: 8
Utilizing drug-target-event relationships to unveil safety patterns in pharmacovigilance
Alexander S. Hauser, Albert J. Kooistra, Eva Sverrisdóttir, et al.
Expert Opinion on Drug Safety (2020) Vol. 19, Iss. 8, pp. 961-968
Closed Access | Times Cited: 6
A systematic review on learning outcomes of pharmacovigilance issues: Undergraduates of pharmacy
Carla Pires
International Journal of Educational Research (2021) Vol. 109, pp. 101845-101845
Closed Access | Times Cited: 6
Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UK
Sieta T. de Vries, Petra Denig, Adriana Andrić, et al.
Drug Safety (2021) Vol. 44, Iss. 10, pp. 1073-1083
Open Access | Times Cited: 6
Pharmacovigilance System in Non-EU Countries
Divya Shukla, Mukesh Nandave, Anoop Kumar, et al.
(2024), pp. 199-225
Closed Access
Pharmacists in the pharmacovigilance system
А. А. Таубэ, V.A. Morozov
Farmaciya (Pharmacy) (2024) Vol. 73, Iss. 3, pp. 48-56
Closed Access
Contribución de los Farmacéuticos Comunitarios en la detección y notificación de reacciones adversas en Andalucía
Miguel Romero, M. Sánchez‐Polo, José Ortíz, et al.
Ars Pharmaceutica (Internet) (2024) Vol. 66, Iss. 1, pp. 25-35
Open Access
Medication Risk Management
Abdul Kader Mohiuddin
INNOVATIONS in pharmacy (2019) Vol. 10, Iss. 1, pp. 9-9
Open Access | Times Cited: 3
Ökonomie der Arzneimitteltherapiesicherheit
Katherine De Bienassis, Laura Esmail, Ruth Lopert, et al.
(2023)
Open Access | Times Cited: 1
Navigating stormy waters: 10 years of operation of the European Union Regulatory Network Incident Management Plan for Medicines for Human Use
Aniello Santoro, Irina Caplanusi, Fergus Sweeney, et al.
Pharmacoepidemiology and Drug Safety (2020) Vol. 29, Iss. 11, pp. 1343-1352
Open Access | Times Cited: 1
Adverse drug reaction reporting for more than a decade: The need for pharmacovigilance policy implementation in Turkey
Zakir Khan, Yusuf Karataş
Journal of Taibah University Medical Sciences (2022) Vol. 17, Iss. 2, pp. 340-342
Open Access | Times Cited: 1
Patient Preferences for Rituximab Additional Risk Minimization Measures: Results From an International Online Survey
Kristyna Schneiderova, Nathalie Bere, Doris I. Stenver, et al.
Journal of Patient Safety (2021) Vol. 18, Iss. 4, pp. 331-336
Open Access | Times Cited: 1
Signal Management: Updated Requirements of the EAEU Good Pharmacovigilance Practice
А. В. Матвеев, А. Е. Крашенинников, A. Yu. Zelinskaya
Safety and Risk of Pharmacotherapy (2023) Vol. 11, Iss. 1, pp. 38-45
Open Access
Data-Driven Identification of Factors That Predict the Quality of Adverse Event Reports for Malaysia Using vigiGrade and Interpretable Machine Learning: A 15-Year Analysis of QUEST and VigiBase (Preprint)
Sim Mei Choo, Daniele Sartori, Sing Chet Lee, et al.
(2023)
Open Access
Page 1

Scroll to top